| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| AKBA | AKBA | Shares | USD | XNCM |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| AKBA | AKBA | Shares | USD | XNCM |
Akebia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutics for kidney disease. It has a nephrology-focused commercial team and a robust development organization. The company has two FDA-approved products and collaborates with medical and biopharmaceutical communities, as well as patient organizations, to improve care for individuals affected by kidney disease. Akebia operates from Cambridge, Massachusetts.
No recent RNS announcements for AKBA across AKBA.
No recent RNS announcements for AKBA across AKBA.